nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER3—mammary gland—breast cancer	0.0131	0.0832	CbGeAlD
Misoprostol—PTGER4—epithelium—breast cancer	0.00861	0.0547	CbGeAlD
Misoprostol—PTGER2—endometrium—breast cancer	0.00787	0.05	CbGeAlD
Misoprostol—PTGER4—endometrium—breast cancer	0.00772	0.0491	CbGeAlD
Misoprostol—PTGER2—uterus—breast cancer	0.00725	0.0461	CbGeAlD
Misoprostol—PTGER4—uterus—breast cancer	0.00712	0.0452	CbGeAlD
Misoprostol—PTGER2—adipose tissue—breast cancer	0.00709	0.045	CbGeAlD
Misoprostol—PTGER4—adipose tissue—breast cancer	0.00696	0.0442	CbGeAlD
Misoprostol—PTGER2—female reproductive system—breast cancer	0.00652	0.0414	CbGeAlD
Misoprostol—PTGER4—female reproductive system—breast cancer	0.0064	0.0406	CbGeAlD
Misoprostol—PTGER2—adrenal gland—breast cancer	0.00636	0.0404	CbGeAlD
Misoprostol—PTGER4—adrenal gland—breast cancer	0.00624	0.0397	CbGeAlD
Misoprostol—PTGER2—bone marrow—breast cancer	0.00615	0.0391	CbGeAlD
Misoprostol—PTGER3—uterus—breast cancer	0.00603	0.0383	CbGeAlD
Misoprostol—PTGER2—female gonad—breast cancer	0.00593	0.0377	CbGeAlD
Misoprostol—PTGER3—adipose tissue—breast cancer	0.00589	0.0374	CbGeAlD
Misoprostol—PTGER4—female gonad—breast cancer	0.00582	0.037	CbGeAlD
Misoprostol—PTGER3—female reproductive system—breast cancer	0.00542	0.0344	CbGeAlD
Misoprostol—PTGER4—endocrine gland—breast cancer	0.00541	0.0344	CbGeAlD
Misoprostol—PTGER3—adrenal gland—breast cancer	0.00529	0.0336	CbGeAlD
Misoprostol—PTGER3—female gonad—breast cancer	0.00493	0.0313	CbGeAlD
Misoprostol—Alprostadil—PTGER1—breast cancer	0.00491	0.409	CrCbGaD
Misoprostol—PTGER3—endocrine gland—breast cancer	0.00458	0.0291	CbGeAlD
Misoprostol—PTGER2—lymph node—breast cancer	0.00381	0.0242	CbGeAlD
Misoprostol—PTGER4—lymph node—breast cancer	0.00374	0.0238	CbGeAlD
Misoprostol—PTGER3—lymph node—breast cancer	0.00317	0.0201	CbGeAlD
Misoprostol—Dinoprostone—PTGER1—breast cancer	0.00302	0.252	CrCbGaD
Misoprostol—Dinoprostone—HPGDS—breast cancer	0.00205	0.171	CrCbGaD
Misoprostol—Dinoprostone—SLCO1B1—breast cancer	0.00138	0.115	CrCbGaD
Misoprostol—Dinoprostone—CYP19A1—breast cancer	0.000637	0.0532	CrCbGaD
Misoprostol—Myalgia—Docetaxel—breast cancer	0.000144	0.000295	CcSEcCtD
Misoprostol—Chest pain—Docetaxel—breast cancer	0.000144	0.000295	CcSEcCtD
Misoprostol—Arthralgia—Docetaxel—breast cancer	0.000144	0.000295	CcSEcCtD
Misoprostol—Loss of consciousness—Capecitabine—breast cancer	0.000144	0.000295	CcSEcCtD
Misoprostol—Nausea—Vinorelbine—breast cancer	0.000144	0.000294	CcSEcCtD
Misoprostol—Dyspepsia—Paclitaxel—breast cancer	0.000144	0.000293	CcSEcCtD
Misoprostol—Asthenia—Irinotecan—breast cancer	0.000144	0.000293	CcSEcCtD
Misoprostol—Asthenia—Mitoxantrone—breast cancer	0.000144	0.000293	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—breast cancer	0.000143	0.000293	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—breast cancer	0.000142	0.00029	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—breast cancer	0.000142	0.00029	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—breast cancer	0.000142	0.00029	CcSEcCtD
Misoprostol—Hypertension—Capecitabine—breast cancer	0.000142	0.000289	CcSEcCtD
Misoprostol—Hypersensitivity—Fluorouracil—breast cancer	0.000141	0.000288	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000141	0.000288	CcSEcCtD
Misoprostol—Fatigue—Paclitaxel—breast cancer	0.000141	0.000287	CcSEcCtD
Misoprostol—Asthenia—Gemcitabine—breast cancer	0.00014	0.000286	CcSEcCtD
Misoprostol—Myalgia—Capecitabine—breast cancer	0.00014	0.000285	CcSEcCtD
Misoprostol—Arthralgia—Capecitabine—breast cancer	0.00014	0.000285	CcSEcCtD
Misoprostol—Chest pain—Capecitabine—breast cancer	0.00014	0.000285	CcSEcCtD
Misoprostol—Constipation—Paclitaxel—breast cancer	0.00014	0.000285	CcSEcCtD
Misoprostol—Pain—Paclitaxel—breast cancer	0.00014	0.000285	CcSEcCtD
Misoprostol—Haematuria—Epirubicin—breast cancer	0.00014	0.000285	CcSEcCtD
Misoprostol—Confusional state—Docetaxel—breast cancer	0.000139	0.000285	CcSEcCtD
Misoprostol—Anxiety—Capecitabine—breast cancer	0.000139	0.000284	CcSEcCtD
Misoprostol—Oedema—Docetaxel—breast cancer	0.000138	0.000283	CcSEcCtD
Misoprostol—Anaphylactic shock—Docetaxel—breast cancer	0.000138	0.000283	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—breast cancer	0.000138	0.000282	CcSEcCtD
Misoprostol—Nausea—Thiotepa—breast cancer	0.000138	0.000281	CcSEcCtD
Misoprostol—Infection—Docetaxel—breast cancer	0.000137	0.000281	CcSEcCtD
Misoprostol—Diarrhoea—Mitoxantrone—breast cancer	0.000137	0.00028	CcSEcCtD
Misoprostol—Diarrhoea—Irinotecan—breast cancer	0.000137	0.00028	CcSEcCtD
Misoprostol—Pneumonia—Doxorubicin—breast cancer	0.000136	0.000278	CcSEcCtD
Misoprostol—Shock—Docetaxel—breast cancer	0.000136	0.000278	CcSEcCtD
Misoprostol—Thrombocytopenia—Docetaxel—breast cancer	0.000135	0.000277	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—breast cancer	0.000135	0.000277	CcSEcCtD
Misoprostol—Visual impairment—Methotrexate—breast cancer	0.000135	0.000276	CcSEcCtD
Misoprostol—Confusional state—Capecitabine—breast cancer	0.000135	0.000276	CcSEcCtD
Misoprostol—Feeling abnormal—Paclitaxel—breast cancer	0.000135	0.000275	CcSEcCtD
Misoprostol—Oedema—Capecitabine—breast cancer	0.000134	0.000274	CcSEcCtD
Misoprostol—Gastrointestinal pain—Paclitaxel—breast cancer	0.000133	0.000273	CcSEcCtD
Misoprostol—Diarrhoea—Gemcitabine—breast cancer	0.000133	0.000272	CcSEcCtD
Misoprostol—Infection—Capecitabine—breast cancer	0.000133	0.000272	CcSEcCtD
Misoprostol—Neuropathy peripheral—Doxorubicin—breast cancer	0.000133	0.000271	CcSEcCtD
Misoprostol—Dizziness—Irinotecan—breast cancer	0.000132	0.00027	CcSEcCtD
Misoprostol—Shock—Capecitabine—breast cancer	0.000132	0.000269	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—breast cancer	0.000132	0.000269	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—breast cancer	0.000132	0.000269	CcSEcCtD
Misoprostol—Diarrhoea—Fluorouracil—breast cancer	0.000131	0.000268	CcSEcCtD
Misoprostol—Thrombocytopenia—Capecitabine—breast cancer	0.000131	0.000268	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—breast cancer	0.000131	0.000267	CcSEcCtD
Misoprostol—Hyperhidrosis—Capecitabine—breast cancer	0.000129	0.000264	CcSEcCtD
Misoprostol—Hypotension—Docetaxel—breast cancer	0.000129	0.000264	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—breast cancer	0.000129	0.000264	CcSEcCtD
Misoprostol—Body temperature increased—Paclitaxel—breast cancer	0.000129	0.000264	CcSEcCtD
Misoprostol—Abdominal pain—Paclitaxel—breast cancer	0.000129	0.000264	CcSEcCtD
Misoprostol—Epistaxis—Doxorubicin—breast cancer	0.000128	0.000261	CcSEcCtD
Misoprostol—Vomiting—Irinotecan—breast cancer	0.000127	0.00026	CcSEcCtD
Misoprostol—Vomiting—Mitoxantrone—breast cancer	0.000127	0.00026	CcSEcCtD
Misoprostol—Immune system disorder—Methotrexate—breast cancer	0.000127	0.000259	CcSEcCtD
Misoprostol—Dizziness—Fluorouracil—breast cancer	0.000127	0.000259	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—breast cancer	0.000127	0.000259	CcSEcCtD
Misoprostol—Rash—Mitoxantrone—breast cancer	0.000126	0.000258	CcSEcCtD
Misoprostol—Rash—Irinotecan—breast cancer	0.000126	0.000258	CcSEcCtD
Misoprostol—Dermatitis—Mitoxantrone—breast cancer	0.000126	0.000258	CcSEcCtD
Misoprostol—Dermatitis—Irinotecan—breast cancer	0.000126	0.000258	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000126	0.000257	CcSEcCtD
Misoprostol—Chills—Methotrexate—breast cancer	0.000126	0.000257	CcSEcCtD
Misoprostol—Headache—Mitoxantrone—breast cancer	0.000125	0.000256	CcSEcCtD
Misoprostol—Headache—Irinotecan—breast cancer	0.000125	0.000256	CcSEcCtD
Misoprostol—Hypotension—Capecitabine—breast cancer	0.000125	0.000256	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—breast cancer	0.000124	0.000253	CcSEcCtD
Misoprostol—Vomiting—Gemcitabine—breast cancer	0.000124	0.000253	CcSEcCtD
Misoprostol—Dyspnoea—Docetaxel—breast cancer	0.000123	0.000252	CcSEcCtD
Misoprostol—Somnolence—Docetaxel—breast cancer	0.000123	0.000251	CcSEcCtD
Misoprostol—Rash—Gemcitabine—breast cancer	0.000123	0.000251	CcSEcCtD
Misoprostol—Dermatitis—Gemcitabine—breast cancer	0.000123	0.000251	CcSEcCtD
Misoprostol—Tinnitus—Epirubicin—breast cancer	0.000122	0.00025	CcSEcCtD
Misoprostol—Headache—Gemcitabine—breast cancer	0.000122	0.000249	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000122	0.000249	CcSEcCtD
Misoprostol—Vomiting—Fluorouracil—breast cancer	0.000122	0.000249	CcSEcCtD
Misoprostol—Dyspepsia—Docetaxel—breast cancer	0.000122	0.000249	CcSEcCtD
Misoprostol—Rash—Fluorouracil—breast cancer	0.000121	0.000247	CcSEcCtD
Misoprostol—Dermatitis—Fluorouracil—breast cancer	0.000121	0.000247	CcSEcCtD
Misoprostol—Hypersensitivity—Paclitaxel—breast cancer	0.00012	0.000246	CcSEcCtD
Misoprostol—Headache—Fluorouracil—breast cancer	0.00012	0.000245	CcSEcCtD
Misoprostol—Dyspnoea—Capecitabine—breast cancer	0.000119	0.000244	CcSEcCtD
Misoprostol—Fatigue—Docetaxel—breast cancer	0.000119	0.000244	CcSEcCtD
Misoprostol—Nausea—Mitoxantrone—breast cancer	0.000119	0.000243	CcSEcCtD
Misoprostol—Nausea—Irinotecan—breast cancer	0.000119	0.000243	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—breast cancer	0.000119	0.000242	CcSEcCtD
Misoprostol—Pain—Docetaxel—breast cancer	0.000118	0.000242	CcSEcCtD
Misoprostol—Constipation—Docetaxel—breast cancer	0.000118	0.000242	CcSEcCtD
Misoprostol—Back pain—Methotrexate—breast cancer	0.000118	0.000241	CcSEcCtD
Misoprostol—Dyspepsia—Capecitabine—breast cancer	0.000118	0.000241	CcSEcCtD
Misoprostol—Chills—Epirubicin—breast cancer	0.000118	0.000241	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—breast cancer	0.000117	0.00024	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—breast cancer	0.000117	0.000239	CcSEcCtD
Misoprostol—Asthenia—Paclitaxel—breast cancer	0.000117	0.000239	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—breast cancer	0.000116	0.000237	CcSEcCtD
Misoprostol—Nausea—Gemcitabine—breast cancer	0.000116	0.000237	CcSEcCtD
Misoprostol—Fatigue—Capecitabine—breast cancer	0.000115	0.000236	CcSEcCtD
Misoprostol—Pain—Capecitabine—breast cancer	0.000115	0.000234	CcSEcCtD
Misoprostol—Constipation—Capecitabine—breast cancer	0.000115	0.000234	CcSEcCtD
Misoprostol—Feeling abnormal—Docetaxel—breast cancer	0.000114	0.000233	CcSEcCtD
Misoprostol—Nausea—Fluorouracil—breast cancer	0.000114	0.000233	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—breast cancer	0.000113	0.000231	CcSEcCtD
Misoprostol—Gastrointestinal pain—Docetaxel—breast cancer	0.000113	0.000231	CcSEcCtD
Misoprostol—Anaemia—Methotrexate—breast cancer	0.000113	0.000231	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—breast cancer	0.000113	0.00023	CcSEcCtD
Misoprostol—Diarrhoea—Paclitaxel—breast cancer	0.000112	0.000228	CcSEcCtD
Misoprostol—Back pain—Epirubicin—breast cancer	0.000111	0.000226	CcSEcCtD
Misoprostol—Feeling abnormal—Capecitabine—breast cancer	0.00011	0.000225	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—breast cancer	0.00011	0.000225	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—breast cancer	0.00011	0.000224	CcSEcCtD
Misoprostol—Gastrointestinal pain—Capecitabine—breast cancer	0.00011	0.000224	CcSEcCtD
Misoprostol—Abdominal pain—Docetaxel—breast cancer	0.000109	0.000223	CcSEcCtD
Misoprostol—Body temperature increased—Docetaxel—breast cancer	0.000109	0.000223	CcSEcCtD
Misoprostol—Chills—Doxorubicin—breast cancer	0.000109	0.000223	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—breast cancer	0.000109	0.000222	CcSEcCtD
Misoprostol—Dizziness—Paclitaxel—breast cancer	0.000108	0.00022	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—breast cancer	0.000107	0.000219	CcSEcCtD
Misoprostol—Abdominal pain—Capecitabine—breast cancer	0.000106	0.000216	CcSEcCtD
Misoprostol—Body temperature increased—Capecitabine—breast cancer	0.000106	0.000216	CcSEcCtD
Misoprostol—Anaemia—Epirubicin—breast cancer	0.000106	0.000216	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—breast cancer	0.000104	0.000213	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—breast cancer	0.000104	0.000212	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—breast cancer	0.000104	0.000212	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—breast cancer	0.000104	0.000212	CcSEcCtD
Misoprostol—Vomiting—Paclitaxel—breast cancer	0.000104	0.000212	CcSEcCtD
Misoprostol—Rash—Paclitaxel—breast cancer	0.000103	0.00021	CcSEcCtD
Misoprostol—Dermatitis—Paclitaxel—breast cancer	0.000103	0.00021	CcSEcCtD
Misoprostol—Syncope—Epirubicin—breast cancer	0.000103	0.000209	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—breast cancer	0.000102	0.000209	CcSEcCtD
Misoprostol—Headache—Paclitaxel—breast cancer	0.000102	0.000209	CcSEcCtD
Misoprostol—Hypersensitivity—Docetaxel—breast cancer	0.000102	0.000208	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—breast cancer	0.000102	0.000208	CcSEcCtD
Misoprostol—Confusional state—Methotrexate—breast cancer	0.000101	0.000205	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—breast cancer	0.0001	0.000205	CcSEcCtD
Misoprostol—Anaphylactic shock—Methotrexate—breast cancer	9.97e-05	0.000204	CcSEcCtD
Misoprostol—Asthenia—Docetaxel—breast cancer	9.93e-05	0.000203	CcSEcCtD
Misoprostol—Infection—Methotrexate—breast cancer	9.91e-05	0.000202	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—breast cancer	9.87e-05	0.000202	CcSEcCtD
Misoprostol—Hypersensitivity—Capecitabine—breast cancer	9.87e-05	0.000202	CcSEcCtD
Misoprostol—Anaemia—Doxorubicin—breast cancer	9.78e-05	0.0002	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—breast cancer	9.76e-05	0.000199	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—breast cancer	9.73e-05	0.000199	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—breast cancer	9.73e-05	0.000199	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—breast cancer	9.73e-05	0.000199	CcSEcCtD
Misoprostol—Anxiety—Epirubicin—breast cancer	9.7e-05	0.000198	CcSEcCtD
Misoprostol—Nausea—Paclitaxel—breast cancer	9.7e-05	0.000198	CcSEcCtD
Misoprostol—Hyperhidrosis—Methotrexate—breast cancer	9.64e-05	0.000197	CcSEcCtD
Misoprostol—Asthenia—Capecitabine—breast cancer	9.61e-05	0.000196	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—breast cancer	9.49e-05	0.000194	CcSEcCtD
Misoprostol—Diarrhoea—Docetaxel—breast cancer	9.47e-05	0.000193	CcSEcCtD
Misoprostol—Confusional state—Epirubicin—breast cancer	9.41e-05	0.000192	CcSEcCtD
Misoprostol—Oedema—Epirubicin—breast cancer	9.33e-05	0.000191	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—breast cancer	9.33e-05	0.000191	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—breast cancer	9.32e-05	0.00019	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—breast cancer	9.3e-05	0.00019	CcSEcCtD
Misoprostol—Infection—Epirubicin—breast cancer	9.27e-05	0.000189	CcSEcCtD
Misoprostol—Shock—Epirubicin—breast cancer	9.18e-05	0.000188	CcSEcCtD
Misoprostol—Diarrhoea—Capecitabine—breast cancer	9.16e-05	0.000187	CcSEcCtD
Misoprostol—Dizziness—Docetaxel—breast cancer	9.15e-05	0.000187	CcSEcCtD
Misoprostol—Thrombocytopenia—Epirubicin—breast cancer	9.14e-05	0.000187	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—breast cancer	9.13e-05	0.000187	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—breast cancer	9.08e-05	0.000186	CcSEcCtD
Misoprostol—Hyperhidrosis—Epirubicin—breast cancer	9.02e-05	0.000184	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—breast cancer	9.01e-05	0.000184	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—breast cancer	9.01e-05	0.000184	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—breast cancer	9.01e-05	0.000184	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—breast cancer	8.98e-05	0.000183	CcSEcCtD
Misoprostol—Dyspnoea—Methotrexate—breast cancer	8.89e-05	0.000182	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—breast cancer	8.86e-05	0.000181	CcSEcCtD
Misoprostol—Dizziness—Capecitabine—breast cancer	8.86e-05	0.000181	CcSEcCtD
Misoprostol—Vomiting—Docetaxel—breast cancer	8.8e-05	0.00018	CcSEcCtD
Misoprostol—Dyspepsia—Methotrexate—breast cancer	8.78e-05	0.000179	CcSEcCtD
Misoprostol—Rash—Docetaxel—breast cancer	8.72e-05	0.000178	CcSEcCtD
Misoprostol—Hypotension—Epirubicin—breast cancer	8.72e-05	0.000178	CcSEcCtD
Misoprostol—Dermatitis—Docetaxel—breast cancer	8.71e-05	0.000178	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—breast cancer	8.71e-05	0.000178	CcSEcCtD
Misoprostol—Headache—Docetaxel—breast cancer	8.67e-05	0.000177	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—breast cancer	8.63e-05	0.000176	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—breast cancer	8.63e-05	0.000176	CcSEcCtD
Misoprostol—Fatigue—Methotrexate—breast cancer	8.6e-05	0.000176	CcSEcCtD
Misoprostol—Infection—Doxorubicin—breast cancer	8.58e-05	0.000175	CcSEcCtD
Misoprostol—Pain—Methotrexate—breast cancer	8.53e-05	0.000174	CcSEcCtD
Misoprostol—Vomiting—Capecitabine—breast cancer	8.52e-05	0.000174	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—breast cancer	8.5e-05	0.000174	CcSEcCtD
Misoprostol—Shock—Doxorubicin—breast cancer	8.49e-05	0.000174	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—breast cancer	8.45e-05	0.000173	CcSEcCtD
Misoprostol—Rash—Capecitabine—breast cancer	8.45e-05	0.000173	CcSEcCtD
Misoprostol—Dermatitis—Capecitabine—breast cancer	8.44e-05	0.000172	CcSEcCtD
Misoprostol—Headache—Capecitabine—breast cancer	8.39e-05	0.000171	CcSEcCtD
Misoprostol—Hyperhidrosis—Doxorubicin—breast cancer	8.35e-05	0.00017	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—breast cancer	8.32e-05	0.00017	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—breast cancer	8.3e-05	0.000169	CcSEcCtD
Misoprostol—Nausea—Docetaxel—breast cancer	8.22e-05	0.000168	CcSEcCtD
Misoprostol—Feeling abnormal—Methotrexate—breast cancer	8.22e-05	0.000168	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—breast cancer	8.21e-05	0.000168	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—breast cancer	8.15e-05	0.000167	CcSEcCtD
Misoprostol—Hypotension—Doxorubicin—breast cancer	8.07e-05	0.000165	CcSEcCtD
Misoprostol—Fatigue—Epirubicin—breast cancer	8.05e-05	0.000164	CcSEcCtD
Misoprostol—Pain—Epirubicin—breast cancer	7.98e-05	0.000163	CcSEcCtD
Misoprostol—Constipation—Epirubicin—breast cancer	7.98e-05	0.000163	CcSEcCtD
Misoprostol—Nausea—Capecitabine—breast cancer	7.96e-05	0.000163	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—breast cancer	7.88e-05	0.000161	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—breast cancer	7.88e-05	0.000161	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.87e-05	0.000161	CcSEcCtD
Misoprostol—Dyspnoea—Doxorubicin—breast cancer	7.7e-05	0.000157	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—breast cancer	7.69e-05	0.000157	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—breast cancer	7.68e-05	0.000157	CcSEcCtD
Misoprostol—Gastrointestinal pain—Epirubicin—breast cancer	7.63e-05	0.000156	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—breast cancer	7.6e-05	0.000155	CcSEcCtD
Misoprostol—Fatigue—Doxorubicin—breast cancer	7.44e-05	0.000152	CcSEcCtD
Misoprostol—Pain—Doxorubicin—breast cancer	7.38e-05	0.000151	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—breast cancer	7.38e-05	0.000151	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—breast cancer	7.38e-05	0.000151	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—breast cancer	7.38e-05	0.000151	CcSEcCtD
Misoprostol—Hypersensitivity—Methotrexate—breast cancer	7.35e-05	0.00015	CcSEcCtD
Misoprostol—Asthenia—Methotrexate—breast cancer	7.15e-05	0.000146	CcSEcCtD
Misoprostol—Feeling abnormal—Doxorubicin—breast cancer	7.12e-05	0.000145	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—breast cancer	7.06e-05	0.000144	CcSEcCtD
Misoprostol—Hypersensitivity—Epirubicin—breast cancer	6.88e-05	0.00014	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—breast cancer	6.83e-05	0.000139	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—breast cancer	6.83e-05	0.000139	CcSEcCtD
Misoprostol—Diarrhoea—Methotrexate—breast cancer	6.82e-05	0.000139	CcSEcCtD
Misoprostol—Asthenia—Epirubicin—breast cancer	6.7e-05	0.000137	CcSEcCtD
Misoprostol—Dizziness—Methotrexate—breast cancer	6.59e-05	0.000135	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PLG—breast cancer	6.55e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CG—breast cancer	6.53e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT2—breast cancer	6.48e-05	0.00019	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGF10—breast cancer	6.44e-05	0.000189	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—breast cancer	6.38e-05	0.00013	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—SPP1—breast cancer	6.38e-05	0.000187	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOTCH2—breast cancer	6.38e-05	0.000187	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HSP90AA1—breast cancer	6.38e-05	0.000187	CbGpPWpGaD
Misoprostol—Hypersensitivity—Doxorubicin—breast cancer	6.36e-05	0.00013	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CXCL8—breast cancer	6.35e-05	0.000186	CbGpPWpGaD
Misoprostol—Vomiting—Methotrexate—breast cancer	6.34e-05	0.000129	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CD—breast cancer	6.32e-05	0.000185	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB3—breast cancer	6.31e-05	0.000185	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGFR2—breast cancer	6.3e-05	0.000185	CbGpPWpGaD
Misoprostol—Rash—Methotrexate—breast cancer	6.29e-05	0.000128	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—breast cancer	6.28e-05	0.000128	CcSEcCtD
Misoprostol—Headache—Methotrexate—breast cancer	6.25e-05	0.000128	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CD—breast cancer	6.22e-05	0.000182	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PDGFA—breast cancer	6.22e-05	0.000182	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PRL—breast cancer	6.2e-05	0.000182	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AGTR1—breast cancer	6.2e-05	0.000182	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—breast cancer	6.19e-05	0.000127	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—breast cancer	6.17e-05	0.000126	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TGFBR2—breast cancer	6.13e-05	0.00018	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STK11—breast cancer	6.11e-05	0.000179	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ADAM10—breast cancer	6.11e-05	0.000179	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL2—breast cancer	6.07e-05	0.000178	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TERT—breast cancer	6.04e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PLG—breast cancer	6.04e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ITPR1—breast cancer	6.03e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT5A—breast cancer	5.99e-05	0.000176	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB4—breast cancer	5.99e-05	0.000176	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP3—breast cancer	5.99e-05	0.000176	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT2—breast cancer	5.98e-05	0.000175	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CB—breast cancer	5.97e-05	0.000175	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGF10—breast cancer	5.95e-05	0.000174	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—breast cancer	5.93e-05	0.000121	CcSEcCtD
Misoprostol—Nausea—Methotrexate—breast cancer	5.92e-05	0.000121	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—breast cancer	5.91e-05	0.000121	CcSEcCtD
Misoprostol—Rash—Epirubicin—breast cancer	5.88e-05	0.00012	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—breast cancer	5.88e-05	0.00012	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FGFR1—breast cancer	5.87e-05	0.000172	CbGpPWpGaD
Misoprostol—Headache—Epirubicin—breast cancer	5.85e-05	0.000119	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—SMAD4—breast cancer	5.8e-05	0.00017	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HIF1A—breast cancer	5.78e-05	0.000169	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1R—breast cancer	5.77e-05	0.000169	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CD—breast cancer	5.74e-05	0.000168	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL8—breast cancer	5.74e-05	0.000168	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDGFA—breast cancer	5.74e-05	0.000168	CbGpPWpGaD
Misoprostol—Dizziness—Doxorubicin—breast cancer	5.71e-05	0.000117	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—HES1—breast cancer	5.66e-05	0.000166	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFBR2—breast cancer	5.66e-05	0.000166	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LEP—breast cancer	5.64e-05	0.000165	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NCOR1—breast cancer	5.63e-05	0.000165	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PLA2G4A—breast cancer	5.63e-05	0.000165	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CAV1—breast cancer	5.59e-05	0.000164	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CSF2—breast cancer	5.57e-05	0.000163	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGF1—breast cancer	5.57e-05	0.000163	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ITPR1—breast cancer	5.57e-05	0.000163	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—RAF1—breast cancer	5.56e-05	0.000163	CbGpPWpGaD
Misoprostol—Nausea—Epirubicin—breast cancer	5.54e-05	0.000113	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ERBB4—breast cancer	5.53e-05	0.000162	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT5A—breast cancer	5.53e-05	0.000162	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NRG1—breast cancer	5.53e-05	0.000162	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP3—breast cancer	5.53e-05	0.000162	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KDR—breast cancer	5.53e-05	0.000162	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CB—breast cancer	5.51e-05	0.000162	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—breast cancer	5.49e-05	0.000112	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—H2AFX—breast cancer	5.49e-05	0.000161	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—breast cancer	5.49e-05	0.000161	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—E2F1—breast cancer	5.45e-05	0.00016	CbGpPWpGaD
Misoprostol—Rash—Doxorubicin—breast cancer	5.44e-05	0.000111	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—breast cancer	5.44e-05	0.000111	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CB—breast cancer	5.42e-05	0.000159	CbGpPWpGaD
Misoprostol—Headache—Doxorubicin—breast cancer	5.41e-05	0.00011	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—ESR1—breast cancer	5.39e-05	0.000158	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SMAD4—breast cancer	5.35e-05	0.000157	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FN1—breast cancer	5.32e-05	0.000156	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1R—breast cancer	5.32e-05	0.000156	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL8—breast cancer	5.3e-05	0.000155	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NFKBIA—breast cancer	5.26e-05	0.000154	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SPP1—breast cancer	5.24e-05	0.000154	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HES1—breast cancer	5.23e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL8—breast cancer	5.21e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOTCH1—breast cancer	5.21e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PLA2G4A—breast cancer	5.2e-05	0.000152	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NCOR1—breast cancer	5.2e-05	0.000152	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB3—breast cancer	5.18e-05	0.000152	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGFR2—breast cancer	5.17e-05	0.000152	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGF1—breast cancer	5.14e-05	0.000151	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CSF2—breast cancer	5.14e-05	0.000151	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—breast cancer	5.13e-05	0.000105	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—RAF1—breast cancer	5.13e-05	0.00015	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NRG1—breast cancer	5.1e-05	0.00015	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CG—breast cancer	5.09e-05	0.000149	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KIT—breast cancer	5.09e-05	0.000149	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APC—breast cancer	5.09e-05	0.000149	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—H2AFX—breast cancer	5.06e-05	0.000149	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—breast cancer	5.06e-05	0.000148	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGF—breast cancer	5.03e-05	0.000148	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—E2F1—breast cancer	5.03e-05	0.000147	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CB—breast cancer	5.01e-05	0.000147	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—breast cancer	4.98e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TERT—breast cancer	4.96e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—MAPK3—breast cancer	4.88e-05	0.000143	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SPP1—breast cancer	4.83e-05	0.000142	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGFR1—breast cancer	4.82e-05	0.000141	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL8—breast cancer	4.81e-05	0.000141	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BRAF—breast cancer	4.79e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB3—breast cancer	4.78e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGFR2—breast cancer	4.77e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HIF1A—breast cancer	4.75e-05	0.000139	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1—breast cancer	4.66e-05	0.000137	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT2—breast cancer	4.66e-05	0.000137	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—EGFR—breast cancer	4.64e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LEP—breast cancer	4.63e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—breast cancer	4.6e-05	0.000135	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CAV1—breast cancer	4.59e-05	0.000135	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TERT—breast cancer	4.58e-05	0.000134	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KDR—breast cancer	4.54e-05	0.000133	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CD—breast cancer	4.48e-05	0.000131	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGFR1—breast cancer	4.45e-05	0.00013	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—breast cancer	4.43e-05	0.00013	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SERPINE1—breast cancer	4.43e-05	0.00013	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—breast cancer	4.42e-05	0.00013	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—breast cancer	4.38e-05	0.000129	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HIF1A—breast cancer	4.38e-05	0.000128	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FN1—breast cancer	4.37e-05	0.000128	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NFKBIA—breast cancer	4.32e-05	0.000127	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOTCH1—breast cancer	4.28e-05	0.000125	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LEP—breast cancer	4.28e-05	0.000125	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CAV1—breast cancer	4.24e-05	0.000124	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOS3—breast cancer	4.23e-05	0.000124	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KDR—breast cancer	4.19e-05	0.000123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CG—breast cancer	4.18e-05	0.000123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KIT—breast cancer	4.18e-05	0.000123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APC—breast cancer	4.18e-05	0.000123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGF—breast cancer	4.13e-05	0.000121	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ESR1—breast cancer	4.08e-05	0.00012	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FN1—breast cancer	4.03e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—breast cancer	4.03e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MDM2—breast cancer	4.01e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MAPK3—breast cancer	4e-05	0.000117	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RAF1—breast cancer	4e-05	0.000117	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NFKBIA—breast cancer	3.98e-05	0.000117	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RELA—breast cancer	3.98e-05	0.000117	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB2—breast cancer	3.95e-05	0.000116	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOTCH1—breast cancer	3.95e-05	0.000116	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BRAF—breast cancer	3.93e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MTOR—breast cancer	3.9e-05	0.000114	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CB—breast cancer	3.9e-05	0.000114	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APC—breast cancer	3.86e-05	0.000113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KIT—breast cancer	3.86e-05	0.000113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CG—breast cancer	3.86e-05	0.000113	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1—breast cancer	3.83e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT2—breast cancer	3.83e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGF—breast cancer	3.81e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—EGFR—breast cancer	3.81e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL8—breast cancer	3.75e-05	0.00011	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HRAS—breast cancer	3.73e-05	0.000109	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MAPK3—breast cancer	3.7e-05	0.000108	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CD—breast cancer	3.68e-05	0.000108	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1B—breast cancer	3.66e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—breast cancer	3.64e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SERPINE1—breast cancer	3.64e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BRAF—breast cancer	3.63e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—breast cancer	3.62e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—breast cancer	3.6e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CASP3—breast cancer	3.59e-05	0.000105	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—breast cancer	3.58e-05	0.000105	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—breast cancer	3.57e-05	0.000105	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1—breast cancer	3.53e-05	0.000104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT2—breast cancer	3.53e-05	0.000104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EGFR—breast cancer	3.52e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—breast cancer	3.49e-05	0.000102	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JUN—breast cancer	3.49e-05	0.000102	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOS3—breast cancer	3.47e-05	0.000102	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CTNNB1—breast cancer	3.46e-05	0.000101	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CD—breast cancer	3.39e-05	9.95e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—breast cancer	3.39e-05	9.94e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1A—breast cancer	3.38e-05	9.91e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTEN—breast cancer	3.37e-05	9.89e-05	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—breast cancer	3.36e-05	9.85e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SERPINE1—breast cancer	3.36e-05	9.84e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—breast cancer	3.32e-05	9.74e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—breast cancer	3.31e-05	9.7e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK8—breast cancer	3.3e-05	9.67e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MDM2—breast cancer	3.29e-05	9.66e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—breast cancer	3.29e-05	9.64e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RAF1—breast cancer	3.28e-05	9.62e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RELA—breast cancer	3.27e-05	9.58e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB2—breast cancer	3.25e-05	9.52e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CB—breast cancer	3.2e-05	9.4e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MTOR—breast cancer	3.2e-05	9.4e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOS3—breast cancer	3.2e-05	9.39e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SRC—breast cancer	3.13e-05	9.17e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL8—breast cancer	3.08e-05	9.03e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRAS—breast cancer	3.06e-05	8.97e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—breast cancer	3.05e-05	8.95e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—breast cancer	3.05e-05	8.93e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MDM2—breast cancer	3.04e-05	8.91e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RAF1—breast cancer	3.03e-05	8.88e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—breast cancer	3.02e-05	8.84e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RELA—breast cancer	3.02e-05	8.84e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1B—breast cancer	3.01e-05	8.82e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB2—breast cancer	3e-05	8.79e-05	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—breast cancer	2.97e-05	8.72e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MTOR—breast cancer	2.96e-05	8.67e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CB—breast cancer	2.96e-05	8.67e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CASP3—breast cancer	2.95e-05	8.64e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—breast cancer	2.94e-05	8.63e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—breast cancer	2.93e-05	8.59e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK3—breast cancer	2.88e-05	8.45e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—breast cancer	2.87e-05	8.41e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JUN—breast cancer	2.86e-05	8.39e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL8—breast cancer	2.84e-05	8.33e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CTNNB1—breast cancer	2.84e-05	8.33e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRAS—breast cancer	2.82e-05	8.28e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—breast cancer	2.8e-05	8.22e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—breast cancer	2.8e-05	8.2e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—breast cancer	2.79e-05	8.17e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1A—breast cancer	2.78e-05	8.14e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1B—breast cancer	2.78e-05	8.14e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTEN—breast cancer	2.77e-05	8.12e-05	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—breast cancer	2.75e-05	8.05e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGFR—breast cancer	2.74e-05	8.04e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CASP3—breast cancer	2.72e-05	7.97e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—breast cancer	2.72e-05	7.96e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK8—breast cancer	2.71e-05	7.94e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—breast cancer	2.7e-05	7.92e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—breast cancer	2.7e-05	7.92e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—breast cancer	2.65e-05	7.76e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JUN—breast cancer	2.64e-05	7.75e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CTNNB1—breast cancer	2.62e-05	7.69e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—breast cancer	2.59e-05	7.59e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—breast cancer	2.57e-05	7.54e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SRC—breast cancer	2.57e-05	7.53e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1A—breast cancer	2.56e-05	7.51e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTEN—breast cancer	2.56e-05	7.49e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—breast cancer	2.5e-05	7.33e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK8—breast cancer	2.5e-05	7.33e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—breast cancer	2.49e-05	7.31e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—breast cancer	2.48e-05	7.26e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—breast cancer	2.38e-05	6.97e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SRC—breast cancer	2.37e-05	6.95e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK3—breast cancer	2.37e-05	6.94e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—breast cancer	2.31e-05	6.77e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—breast cancer	2.3e-05	6.75e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—breast cancer	2.3e-05	6.75e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—breast cancer	2.3e-05	6.73e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—breast cancer	2.29e-05	6.7e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGFR—breast cancer	2.25e-05	6.6e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRAS—breast cancer	2.2e-05	6.45e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK3—breast cancer	2.18e-05	6.4e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—breast cancer	2.13e-05	6.23e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—breast cancer	2.12e-05	6.23e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—breast cancer	2.12e-05	6.21e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—breast cancer	2.11e-05	6.18e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGFR—breast cancer	2.08e-05	6.09e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—breast cancer	1.96e-05	5.75e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—breast cancer	1.95e-05	5.73e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—breast cancer	1.94e-05	5.7e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—breast cancer	1.89e-05	5.54e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRAS—breast cancer	1.81e-05	5.3e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—breast cancer	1.8e-05	5.29e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—breast cancer	1.74e-05	5.11e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—breast cancer	1.73e-05	5.07e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRAS—breast cancer	1.67e-05	4.89e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—breast cancer	1.6e-05	4.68e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—breast cancer	1.6e-05	4.68e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—breast cancer	1.47e-05	4.32e-05	CbGpPWpGaD
